Arcadia Biosciences
RKDA
EPS for Arcadia Biosciences (RKDA)
EPS in 2023 (TTM): -$21.50
According to Arcadia Biosciences's latest financial reports the company's current EPS (TTM) is -$21.50. In 2022 the company made an earnings per share (EPS) of -$26.15 an increase over its 2021 EPS that were of -$26.36.
EPS history for Arcadia Biosciences from 2014 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$21.50 | -17.78% |
| 2022 | -$26.15 | -0.8% |
| 2021 | -$26.36 | 64.75% |
| 2020 | -$16.00 | -90.78% |
| 2019 | -$173.60 | -25.04% |
| 2018 | -$231.60 | -20.58% |
| 2017 | -$291.60 | -17.63% |
| 2016 | -$354.00 | -25.29% |
| 2015 | -$473.85 | -12.21% |
| 2014 | -$539.78 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Codexis
CDXS | -$0.85 | -96.05% | 🇺🇸 USA |
 ScottsMiracle-Gro SMG | -$6.77 | -68.51% | 🇺🇸 USA |
 American Vanguard AVD | $0.40 | -101.86% | 🇺🇸 USA |